Pharmacogenomics Variability of Lipid-Lowering Therapies in Familial Hypercholesterolemia
<div><p>The exponential expansion of genomic data coupled with the lack of appropriate clinical categorization of the variants is posing a major challenge to conventional medications for many common and rare diseases. To narrow this gap and achieve the goals of personalized medicine, a c...
محفوظ في:
| المؤلف الرئيسي: | Nagham N. Hindi (18526815) (author) |
|---|---|
| مؤلفون آخرون: | Jamil Alenbawi (14056978) (author), Georges Nemer (295984) (author) |
| منشور في: |
2021
|
| الموضوعات: | |
| الوسوم: |
إضافة وسم
لا توجد وسوم, كن أول من يضع وسما على هذه التسجيلة!
|
مواد مشابهة
-
The Digenic Causality in Familial Hypercholesterolemia: Revising the Genotype–Phenotype Correlations of the Disease
حسب: Amina Kamar (295977)
منشور في: (2021) -
LDL-C Targets in Secondary Prevention: How Low Should We Go?
حسب: Karim Bayoumy (3496688)
منشور في: (2019) -
The Prevalence and Genetic Spectrum of Familial Hypercholesterolemia in Qatar Based on Whole Genome Sequencing of 14,000 Subjects
حسب: Ilhame Diboun (3522413)
منشور في: (2022) -
The global burden of adolescent and young adult cancer in 2019: a systematic analysis for the Global Burden of Disease Study 2019
حسب: Elysia M Alvarez (12229352)
منشور في: (2022) -
The role of protective genetic variants in modulating epigenetic aging
حسب: Yosra Bejaoui (8552574)
منشور في: (2025)